Finance

Lists
AIMDW:NASDAQ
Amarillo Biosciences
US$0,044
0,00%
(0,00) 1D
16 āšž.āšˆ., 15 āŧ‚āšĄāš‡ 55 āš™āšēāš—āšĩ 07 āš§āšīāš™āšēāš—āšĩ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AIMDW...
Mkt. cap
9,15 āšĨāŧ‰āšēāš™
Avg. vol.
6,37Â āšžāšąāš™
Volume
0,00
52-wk high
US$0,18
52-wk low
US$0,03
Beta
-3,80
No. of employees
41
Mkt. cap
9,15 āšĨāŧ‰āšēāš™
Avg. vol.
6,37Â āšžāšąāš™
Volume
0,00
52-wk high
US$0,18
52-wk low
US$0,03
Beta
-3,80
No. of employees
41
News stories
From web sources and news partners
kalkine.ca
kalkine.ca
·
12 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
How Did Ainos (NASDAQ:AIMD) Climb From USD 2,167 to USD 642,889 in Quarterly Revenue?
GuruFocus
GuruFocus
·
2 āšĄāš·āŧ‰āšāŧˆāš­āš™
Ainos Inc (AIMD) Reports Explosive Q3 Revenue Growth Amidst Pers
About Amarillo Biosciences
CEO-
Employees41
Founded1984
HeadquartersāšŪāšļāšŠāš•āšąāš™, āŧ€āš—āšąāšāšŠāšąāšŠ, āšŠāš°āšŦāš°āšĨāšąāš”
SectorInformation Technology
IndustryComputers, Peripherals, and Software
Websiteainos.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
2,17Â āšžāšąāš™
11,12Â āšžāšąāš™
161,00
152,00
Cost of goods sold
477,00
1,60Â āšžāšąāš™
763,00
53,00
Cost of revenue
477,00
1,60Â āšžāšąāš™
763,00
53,00
Research and development expenses
1,99 āšĨāŧ‰āšēāš™
2,12 āšĨāŧ‰āšēāš™
1,69 āšĨāŧ‰āšēāš™
1,85 āšĨāŧ‰āšēāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
795,25Â āšžāšąāš™
2,18 āšĨāŧ‰āšēāš™
593,18Â āšžāšąāš™
2,55 āšĨāŧ‰āšēāš™
Operating expense
2,79 āšĨāŧ‰āšēāš™
4,31 āšĨāŧ‰āšēāš™
2,28 āšĨāŧ‰āšēāš™
4,40 āšĨāŧ‰āšēāš™
Total operating expenses
2,79 āšĨāŧ‰āšēāš™
4,31 āšĨāŧ‰āšēāš™
2,28 āšĨāŧ‰āšēāš™
4,40 āšĨāŧ‰āšēāš™
Operating income
-2,78 āšĨāŧ‰āšēāš™
-4,30 āšĨāŧ‰āšēāš™
-2,28 āšĨāŧ‰āšēāš™
-4,40 āšĨāŧ‰āšēāš™
Other non operating income
29,08Â āšžāšąāš™
7,08Â āšžāšąāš™
723,00
4,52Â āšžāšąāš™
EBT including unusual items
-2,93 āšĨāŧ‰āšēāš™
-4,47 āšĨāŧ‰āšēāš™
-2,46 āšĨāŧ‰āšēāš™
-4,59 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-2,93 āšĨāŧ‰āšēāš™
-4,47 āšĨāŧ‰āšēāš™
-2,46 āšĨāŧ‰āšēāš™
-4,59 āšĨāŧ‰āšēāš™
Income tax expense
-
800,00
-
-
Effective tax rate
-
-0,02%
-
-
Other operating expenses
-
-
-
-
Net income
-2,93 āšĨāŧ‰āšēāš™
-4,47 āšĨāŧ‰āšēāš™
-2,46 āšĨāŧ‰āšēāš™
-4,59 āšĨāŧ‰āšēāš™
Net profit margin
-135.288,51%
-40.182,54%
-1.527.826,09%
-3.022.849,34%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-176,58Â āšžāšąāš™
-176,92Â āšžāšąāš™
-176,88Â āšžāšąāš™
-200,16Â āšžāšąāš™
Net interest expenses
-176,58Â āšžāšąāš™
-176,92Â āšžāšąāš™
-176,88Â āšžāšąāš™
-200,16Â āšžāšąāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,58 āšĨāŧ‰āšēāš™
-3,10 āšĨāŧ‰āšēāš™
-1,11 āšĨāŧ‰āšēāš™
-3,21 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-1,10Â āšžāšąāš™
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google